End-of-day quote
Shenzhen S.E.
18:00:00 2024-05-08 EDT
|
5-day change
|
1st Jan Change
|
3.84
CNY
|
-0.26%
|
|
+7.56%
|
-9.22%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,077
|
2,589
|
3,402
|
4,625
|
2,978
|
3,110
|
Enterprise Value (EV)
1 |
2,933
|
3,686
|
5,039
|
5,894
|
4,109
|
4,615
|
P/E ratio
|
69
x
|
28.7
x
|
28.3
x
|
140
x
|
-38
x
|
81.2
x
|
Yield
|
1.16%
|
0.93%
|
-
|
1.75%
|
0.99%
|
1.65%
|
Capitalization / Revenue
|
0.84
x
|
1.09
x
|
1.3
x
|
1.35
x
|
1.18
x
|
1.17
x
|
EV / Revenue
|
1.19
x
|
1.55
x
|
1.93
x
|
1.72
x
|
1.63
x
|
1.74
x
|
EV / EBITDA
|
24.2
x
|
15.5
x
|
15.9
x
|
24.2
x
|
34.2
x
|
23.7
x
|
EV / FCF
|
-13.2
x
|
-25.8
x
|
-9.74
x
|
-50.8
x
|
16.2
x
|
-11.1
x
|
FCF Yield
|
-7.59%
|
-3.87%
|
-10.3%
|
-1.97%
|
6.16%
|
-9.01%
|
Price to Book
|
1.38
x
|
1.65
x
|
2.05
x
|
2.17
x
|
1.46
x
|
1.52
x
|
Nbr of stocks (in thousands)
|
602,058
|
602,058
|
602,058
|
735,270
|
735,270
|
735,270
|
Reference price
2 |
3.450
|
4.300
|
5.650
|
6.290
|
4.050
|
4.230
|
Announcement Date
|
19-03-28
|
20-03-12
|
21-04-20
|
22-04-15
|
23-04-20
|
24-04-19
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,467
|
2,383
|
2,611
|
3,429
|
2,519
|
2,647
|
EBITDA
1 |
121.3
|
237.9
|
315.9
|
243.4
|
120.2
|
194.8
|
EBIT
1 |
56.93
|
170.9
|
227.8
|
82.38
|
-51.21
|
86.04
|
Operating Margin
|
2.31%
|
7.17%
|
8.73%
|
2.4%
|
-2.03%
|
3.25%
|
Earnings before Tax (EBT)
1 |
36.72
|
102.8
|
138.6
|
8.778
|
-142.8
|
13.41
|
Net income
1 |
29.08
|
89.28
|
120.2
|
29.74
|
-78.3
|
38.28
|
Net margin
|
1.18%
|
3.75%
|
4.6%
|
0.87%
|
-3.11%
|
1.45%
|
EPS
2 |
0.0500
|
0.1500
|
0.2000
|
0.0450
|
-0.1065
|
0.0521
|
Free Cash Flow
1 |
-222.6
|
-142.7
|
-517.2
|
-116
|
253.2
|
-415.9
|
FCF margin
|
-9.02%
|
-5.99%
|
-19.81%
|
-3.38%
|
10.05%
|
-15.71%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
210.68%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0400
|
0.0400
|
-
|
0.1100
|
0.0400
|
0.0700
|
Announcement Date
|
19-03-28
|
20-03-12
|
21-04-20
|
22-04-15
|
23-04-20
|
24-04-19
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
856
|
1,098
|
1,637
|
1,269
|
1,131
|
1,505
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
7.056
x
|
4.614
x
|
5.182
x
|
5.214
x
|
9.413
x
|
7.724
x
|
Free Cash Flow
1 |
-223
|
-143
|
-517
|
-116
|
253
|
-416
|
ROE (net income / shareholders' equity)
|
2%
|
5.83%
|
7.31%
|
1.45%
|
-3.98%
|
1.88%
|
ROA (Net income/ Total Assets)
|
1.08%
|
2.87%
|
3.49%
|
1.05%
|
-0.58%
|
1.03%
|
Assets
1 |
2,684
|
3,114
|
3,441
|
2,823
|
13,513
|
3,731
|
Book Value Per Share
2 |
2.490
|
2.600
|
2.760
|
2.900
|
2.770
|
2.780
|
Cash Flow per Share
2 |
0.5200
|
0.7400
|
0.5900
|
1.380
|
2.290
|
1.010
|
Capex
1 |
376
|
375
|
160
|
207
|
5.32
|
192
|
Capex / Sales
|
15.23%
|
15.75%
|
6.13%
|
6.05%
|
0.21%
|
7.25%
|
Announcement Date
|
19-03-28
|
20-03-12
|
21-04-20
|
22-04-15
|
23-04-20
|
24-04-19
|
|
1st Jan change
|
Capi.
|
---|
| -9.22% | 392M | | +6.15% | 105B | | -4.19% | 65.16B | | +51.90% | 42.93B | | +17.59% | 39.48B | | +6.89% | 33.27B | | +12.40% | 19.92B | | +16.25% | 17.49B | | +20.35% | 15.43B | | +9.86% | 15.09B |
Other Commodity Chemicals
|